Continuous glucose monitoring changed diabetes care. Can Nutromics do something similar for hospital drug dosing?
Nutromics has received FDA Breakthrough Device Designation for a wearable patch designed to monitor vancomycin continuously rather than through intermittent laboratory blood draws. Human feasibility data support the concept, but sensor durability, accuracy in critically ill patients and integration into dosing decisions remain the real commercial hurdles.